A novel member of the NF2/ERM/4.1 superfamily with growth suppressing properties in lung cancer
about
Protein 4.1B contributes to the organization of peripheral myelinated axonsAllelic loss on chromosome band 18p11.3 occurs early and reveals heterogeneity in breast cancer progressionThe tumor suppressor DAL-1/4.1B and protein methylation cooperate in inducing apoptosis in MCF-7 breast cancer cells.Role of DNA methylation in renal cell carcinomaStructural Basis of Tumor Suppressor in Lung Cancer 1 (TSLC1) Binding to Differentially Expressed in Adenocarcinoma of the Lung (DAL-1/4.1B)EPB41L5 functions to post-transcriptionally regulate cadherin and integrin during epithelial-mesenchymal transitionPooled analysis of loss of heterozygosity in breast cancer: a genome scan provides comparative evidence for multiple tumor suppressors and identifies novel candidate regions.Expression of liver cancer associated gene HCCA3.Identification of a DNA methylome profile of esophageal squamous cell carcinoma and potential plasma epigenetic biomarkers for early diagnosis.An interaction between {alpha}v{beta}8 integrin and Band 4.1B via a highly conserved region of the Band 4.1 C-terminal domain.Loss of the putative tumor suppressor band 4.1B/Dal1 gene is dispensable for normal development and does not predispose to cancerMicroRNA-223 delivered by platelet-derived microvesicles promotes lung cancer cell invasion via targeting tumor suppressor EPB41L3.Gender-stratified gene and gene-treatment interactions in smoking cessationDynamic regulation of a cell adhesion protein complex including CADM1 by combinatorial analysis of FRAP with exponential curve-fitting.Protein 4.1B suppresses prostate cancer progression and metastasis.Prolonged re-expression of the hypermethylated gene EPB41L3 using artificial transcription factors and epigenetic drugsBand 4.1 proteins regulate integrin-dependent cell spreadingThe membrane-cytoskeletal protein 4.1N is involved in the process of cell adhesion, migration and invasion of breast cancer cellsAberrant expression of the candidate tumor suppressor gene DAL-1 due to hypermethylation in gastric cancer.Integrative Functional Genomics Implicates EPB41 Dysregulation in Hepatocellular Carcinoma Risk.Rolly protein (ROLP)-Epb4.1/3: a potential protein-protein interaction relevant for the maintenance of cell adhesion.Cytoskeletal protein 4.1R negatively regulates T-cell activation by inhibiting the phosphorylation of LATMyelofibrosis involving lymph node: a novel cytogenetic abnormality in a mimicker of mesenchymal neoplasm.A 130-kDa protein 4.1B regulates cell adhesion, spreading, and migration of mouse embryo fibroblasts by influencing actin cytoskeleton organization.Unreported intrinsic disorder in proteins: Disorder emergency room.Credentialing of DNA methylation assays for human genes as diagnostic biomarkers of cervical intraepithelial neoplasia in high-risk HPV positive women.Structure and function of SET and MYND domain-containing proteins.Factor interaction analysis for chromosome 8 and DNA methylation alterations highlights innate immune response suppression and cytoskeletal changes in prostate cancer.DAL-1 attenuates epithelial-to mesenchymal transition in lung cancer.The Drosophila tumor suppressors Expanded and Merlin differentially regulate cell cycle exit, apoptosis, and Wingless signaling.High resolution analysis of the human transcriptome: detection of extensive alternative splicing independent of transcriptional activityThe cytoskeletal protein ezrin regulates EC proliferation and angiogenesis via TNF-alpha-induced transcriptional repression of cyclin A.[Expressions and clinical significances of TSLC1 and 4.1B in non-small cell lung cancer].MicroRNA-26a regulates ANXA1, rather than DAL-1, in the development of lung cancer.Host-cell DNA methylation patterns during high-risk HPV-induced carcinogenesis reveal a heterogeneous nature of cervical pre-cancer
P2860
Q24339344-42FB6CCE-2AC7-4D98-8339-E3C1A6A4288FQ24796515-A28C766A-BE01-445E-A9CC-C996D9A7ED83Q25257451-EFD9B138-9221-47FE-BFCC-956EB332ED39Q26801268-536FE84C-EA5D-47F9-AEBC-BA24D74D42EBQ27666177-8B884942-3CFD-4020-B09E-69B500C76FDCQ28594472-7ADEEACE-5C33-4F56-A59C-54A582EE90ADQ30476046-1EC708EE-F108-4D94-BF1A-07C10D71A6EBQ31039293-DCC58A1D-F374-46DD-97D2-D9BF40AE840EQ33933511-63CF2532-8B72-4A7B-B25E-A644443B9A90Q34015993-A3EDF46D-E688-45F1-8606-7FF355C6AF4FQ34124246-6018EFB5-A722-48D2-9CD3-AA29FFD14940Q35180264-1F5A0AAA-B90E-485C-9B1D-725F615614B3Q35523896-F139D241-631C-4D84-A433-750F5A85E808Q35579299-F09B4843-0330-4D9D-B812-7CDEFAF8F8D9Q35901782-61B33722-A74D-4CD4-8667-C5B8F59F8ED6Q36212723-704E3FC5-75EB-4598-A706-EE45D9183DCDQ36306266-A6391AD0-6A48-451A-8145-D559012C76FCQ36409185-16B19506-61A9-4A6F-82A6-AB925053E920Q36628545-3DF8F1A5-6857-43DE-B87A-4A3A157E1B60Q37152966-BE0D71D2-369E-45BF-B0B9-05D7B2DA1E1DQ37224674-0B3253A9-EABA-41A8-B1E9-A8D0CC6814DCQ37234619-0A30457E-9BA5-4AE6-892F-434F3AE5B9A5Q37397730-47CD8CFA-D4BA-433F-AAF9-1BA215C796DBQ37608511-A472EACA-FF80-4F49-96F2-D2896C92B280Q37649606-36C90A00-3295-4F56-A92F-8D50353D3834Q37706679-9C541AC4-FEEA-4208-A667-09BBF613A5C8Q38314974-8340018B-0E36-41D9-BCE4-8364571A08A4Q38516787-F5856202-84AD-4120-8692-514762AD19C6Q38917822-DE7730C3-7E4C-4DB2-8648-393B55AE5083Q42529926-C9D072E3-9F5E-4F3A-B821-8505EA62642AQ42594172-094DA819-4EA8-4689-9AFF-612BBC58B12CQ42860390-473CA189-395F-434F-8A5D-8B757F6447A7Q53293382-8914CDBA-A4D3-418A-AFFD-FB08E8EE65B9Q54094778-B1AA9441-FC53-41B9-BC94-F1E6D8879535Q58703195-97C4A9AC-11C1-4D04-A25E-AB8A98D5386C
P2860
A novel member of the NF2/ERM/4.1 superfamily with growth suppressing properties in lung cancer
description
1999 nî lūn-bûn
@nan
1999 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
name
A novel member of the NF2/ERM/ ...... sing properties in lung cancer
@ast
A novel member of the NF2/ERM/ ...... sing properties in lung cancer
@en
A novel member of the NF2/ERM/ ...... sing properties in lung cancer
@en-gb
A novel member of the NF2/ERM/ ...... sing properties in lung cancer
@nl
type
label
A novel member of the NF2/ERM/ ...... sing properties in lung cancer
@ast
A novel member of the NF2/ERM/ ...... sing properties in lung cancer
@en
A novel member of the NF2/ERM/ ...... sing properties in lung cancer
@en-gb
A novel member of the NF2/ERM/ ...... sing properties in lung cancer
@nl
prefLabel
A novel member of the NF2/ERM/ ...... sing properties in lung cancer
@ast
A novel member of the NF2/ERM/ ...... sing properties in lung cancer
@en
A novel member of the NF2/ERM/ ...... sing properties in lung cancer
@en-gb
A novel member of the NF2/ERM/ ...... sing properties in lung cancer
@nl
P2093
P1433
P1476
A novel member of the NF2/ERM/ ...... sing properties in lung cancer
@en
P2093
P407
P577
1999-01-01T00:00:00Z